Biomark Diagnostics Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Stock Symbol
  • BUX
Stock Symbol
  • Share Price
  • $0.10
  • (As of Friday Closing)

Biomark Diagnostics General Information

Description

Biomark Diagnostics Inc is a Canada based oncology-focused company. It is engaged in the development of advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Stock Exchange
CNQ
Primary Office
  • 165 - 10551 Shellbridge Way
  • Richmond, British Columbia V6X 2W8
  • Canada
+1 (604) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomark Diagnostics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.10 $0.10 $0.05 - $0.22 $8.45M 72.9M 46.9K -$0.02

Biomark Diagnostics Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 7,387 8,623 3,099 3,313
Revenue 196 198 0 0
EBITDA (909) (905) (416) (566)
Net Income (911) (914) (416) (566)
Total Assets 390 449 26 40
Total Debt 4 6 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biomark Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomark Diagnostics‘s full profile, request access.

Request a free trial

Biomark Diagnostics Executive Team (4)

Name Title Board Seat Contact Info
Rashid Ahmed Founder & Chief Executive Officer
Thomas Malcolm President & Chief Scientific Officer
Brian Cheng Chief Technical Officer
Abbey Abdiye Chief Financial Officer
To view Biomark Diagnostics’s complete executive team members history, request access »